With Reference to the subject cited please find the 34th Annual Report along with the intimation for the financial year 2025-26

34th ANNUAL REPORT 2025-2026 HINDUSTAN BIO SCIENCES LIMITED ANNUAL REPORT 2025-2026 HINDUSTAN BIO SCIENCES LIMITED BOARD OF DIRECTORS: 1) Sri. J.V.R. Mohan Raju - Chairman and Managing Director 2) Smt. J. Uma - Director 3) Sri Jaison George - Director 4) Sri Reji Abraham - Independent Director 5) Sri. B. Nagi Reddy - Independent Director 6) Sri. Prateek Reddy - Independent Director Registered Office address - H.No.8-2-269/S, Plot No.31, Sagar Co-Operative Housing Society, Road No.2, Banjara Hills, Hyderabad – 500 034 Company Identification Number - L26942TG1991PLC013564 Company Secretary & Compliance Officer - Mr. Shailendra Vyas, Chief Financial Officer - Mr. Jaison George Bankers - Axis Bank Ltd, Begumpet Branch, Hyderabad Auditors - M/s VASG & Associates, Chartered Accountants # 503/A, 5th Floor, Kubera Towers Narayanaguda, Hyderabad – 500 029. Ph :040-66849660 E-mail:info@vasg.ca.com vasgassociates@gmail.com Registrars and Share Transfer Agents - M/s. Venture Capital & Corporate Investments Private Limited. AURUM”, 4th & 5th Floors, Plot No.57, Jayabheri Enclave Phase – II, Gachibowli, Hyderabad – 500032, emailinvestor.relations@vccipl.com Landline: 040-23818475/35164940 ANNUAL REPORT 2025-2026 HINDUSTAN BIO SCIENCES LIMITED NOTICE NOTICE IS HEREBY GIVEN THAT THE 34TH ANNUAL GENERAL MEETING OF THE SHAREHOLDERS OF HINDUSTAN BIO SCIENCES LIMITED WILL BE HELD ON WEDNESDAY, 30TH SEPTEMBER 2026 AT 10.00 A.M.AT THE REGISTERED OFFICE OF THE COMPANY AT PLOT NO.31 SAGAR SOCIETY ROAD NO.2, BANJARAHILLS HYDERABAD-500034, TELANGANA TO TRANSACT THE FOLLOWING BUSINESS: ORDINARY BUSINESS: 1. To receive, consider, and adopt the Audited Standalone Financial Statement for the financial year ended March 31, 2026 To receive, consider, and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon and, in this regard, to consider and if thought fit, to pass the following resolution as Ordinary Resolution: “RESOLVED THAT the audited (standalone) financial statement of the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and the Auditors thereon, as circulated to the members, be and are hereby considered and adopted.” 2. To appoint a director in place of Smt. Uma Jampana (DIN: 00912376) who retires by rotation and being eligible, offers herself for re-appointment. In this regard, to consider and if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT Smt. Uma Jampana (DIN: 00912376) be and is hereby re-appointed as a Director of the Company, liable to retire by rotation.” 3. TO CONSIDER THE SCHEME OF REDUCTION OF SHARE CAPITAL OF THE COMPANY. To consider and if, thought fit to pass with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to Section 66 and other applicable provisions, if any, of the Companies Act, 2013 (“Act”) and the rules made thereunder including the National Company Law Tribunal (Procedure for Reduction of Share Capital of Company) Rules, 2016 (“NCLT Rules”) and any other applicable provisions of law (including any statutory amendment(s), modification(s) or re-enactment(s) thereof for the time being in force), the Articles of Association of the Company and subject to the confirmation by the Hon’ble National Company Law Tribunal, Hyderabad Bench (“NCLT”) and such other approvals, consents, permissions and sanctions as may be required to be obtained from appropriate Governmental authorities, departments, offices, institutions, bodies, agencies and/or third parties and subject to the terms and conditions, as may be prescribed while granting such approvals, consents, permissions and sanctions by the NCLT and/or any other appropriate Governmental authorities, departments, offices, institutions, bodies, agencies and/or third parties connected with the Reduction of Share Capital and which may be agreed to by the Board of Directors of the ANNUAL REPORT 2025-2026 HINDUSTAN BIO SCIENCES LIMITED Company (“Board”) (which term shall be deemed to mean and include one or more committee(s) constituted/ to be constituted by the Board), approval of the members of the Company (“Members”) be and is hereby accorded to the Scheme of Reduction of Share Capital (“Scheme”) of the Company by way of reduction of paid- up share capital of the Company from Rs. 2,05,01,600/- (Rupees Two crores Five Lakhs One Thousand Six Hundred only) comprising of 1,02,50,800 (One Crore Two Lakhs Fifty Thousand and Eight Hundred Only) equity shares of Rs. 2/- each to Rs. 92,25,720/- (Rupees Ninety-Two Lakhs Twenty-Five thousand and Seven hundred Twenty only) divided into 46,12,860 (Forty-Six Lakhs Twelve Thousand Eight Hundred and Sixty) equity shares of Rs. 2/- each and such reduction would be effected by writing off the Accumulated Losses of Rs. 1,12,75,880/- (Rupees One Crore Twelve Lakhs Seventy-Five Thousand Eight Hundred Eighty Only) on the Effective Date of the draft Scheme of Reduction of capital (“Scheme”). RESOLVED FURTEHR THAT simultaneously with and as an integral part of the aforesaid reduction and re-organization of share capital, and pursuant to Sections 13, 14 and 61 of the Companies Act, 2013 and subject to approval of the Scheme of Reduction of Share Capital by the Hon'ble National Company Law Tribunal, Hyderabad Bench (“NCLT”), the Authorised Share capital of the Company be altered from Rs. 11,00,00,000/- (Rupees Eleven crores only) divided into 5,50,00,000 (Five Crores Fifty Lakhs only) Equity Shares of Rs.2/- (Rupees Two) each to Rs. 11,00,00,000/- (Rupees Eleven crores only) divided into 1,10,00,000 (One crores Ten Lakhs only) Equity Shares of Rs. 10/- (Rupees Ten) each and consequently the existing Clause V of the Memorandum of Association and Article 5 of the Articles of Association of the company be and is hereby altered by deleting the same and substituting in its place and instead thereof, the following: “Clause V of Memorandum of Association: “Clause V: The Authorised share capital of the company is Rs. 11,00,00,000/- (Rupees Eleven crores only) divided into 1,10,00,000 (One crores Ten Lakhs only) Equity Shares of Rs. 10/- (Rupees Ten) each.” Article 5 of Articles of Association: “Article 5 : The Authorised share capital of the company is Rs. 11,00,00,000/- (Rupees Eleven crores only) divided into 1,10,00,000 (One crores Ten Lakhs only) Equity Shares of Rs. 10/- (Rupees Ten) each to be increased or reduced in accordance with the relevant provisions of Companies Act, 2013.” RESOLVED FURTHER THAT for giving effect to the reduction and consolidation, the entitlement of shareholders shall, subject to the Scheme and applicable laws, be determined such that for every 100 (One Hundred) equity shares of ?2/- each held immediately prior to the Record date, the shareholder shall be entitled to 9 (Nine) equity shares of ?10/- each after giving effect to the reduction and consolidation. RESOLVED FURTHER THAT accordingly, upon the Scheme becoming effective, the total issued and paid-up Equity Share Capital of the Company shall stand reduced and consolidated from Rs. 2,05,01,600/- (Rupees Two crores Five Lakhs One-Thousand Six hundred only) comprising of 1,02,50,800 (One Crore Two Lakhs Fifty Thousand and Eight Hundred) equity shares of Rs. 2/- each, fully paid-up, to Rs. 92,25,720/-(Rupees Ninety-Two Lakhs Twenty-Five ANNUAL REPORT 2025-2026 HINDUSTAN BIO SCIENCES LIMITED Thousand Seven Hundred Twenty Only) divided into 9,22,572 Equity Shares of Rs. 10/- each, fully paid-up. RESOLVED FURTHER THAT the aforesaid reduction of share capital shall be effected by cancellation and extinguishment of 56,37,940 (Fifty-Six Lakhs Thirty-Seven Thousand Nine Hundred Forty) equity shares of ?2/- each, fully paid-up, and the said shares shall, upon the Scheme becoming effective and on the Record Date determined in accordance with the Sc [Showing first 8,000 characters — download PDF for full document]